Dimensional Fund Advisors LP lifted its holdings in Select Medical Holdings Co. (NYSE:SEM – Get Rating) by 1.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,708,986 shares of the health services provider’s stock after purchasing an additional 70,058 shares during the quarter. Dimensional Fund Advisors LP’s holdings in Select Medical were worth $116,924,000 as of its most recent SEC filing.
A number of other institutional investors have also added to or reduced their stakes in SEM. Belpointe Asset Management LLC acquired a new position in shares of Select Medical in the fourth quarter valued at $25,000. IFP Advisors Inc boosted its position in shares of Select Medical by 275.4% in the fourth quarter. IFP Advisors Inc now owns 1,036 shares of the health services provider’s stock valued at $32,000 after acquiring an additional 760 shares during the period. Versant Capital Management Inc lifted its position in Select Medical by 105.2% during the third quarter. Versant Capital Management Inc now owns 1,785 shares of the health services provider’s stock worth $39,000 after purchasing an additional 915 shares during the period. Neo Ivy Capital Management bought a new stake in Select Medical during the third quarter worth about $60,000. Finally, UBS Group AG lifted its position in Select Medical by 252.4% during the first quarter. UBS Group AG now owns 2,844 shares of the health services provider’s stock worth $69,000 after purchasing an additional 2,037 shares during the period. 78.75% of the stock is currently owned by institutional investors and hedge funds.
Select Medical Price Performance
Shares of SEM opened at $28.50 on Friday. Select Medical Holdings Co. has a 12-month low of $18.86 and a 12-month high of $32.31. The business’s fifty day moving average is $27.49 and its 200 day moving average is $26.64. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 2.66. The stock has a market cap of $3.62 billion, a P/E ratio of 20.07, a P/E/G ratio of 1.03 and a beta of 1.39.
Select Medical Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 31st. Stockholders of record on Thursday, May 18th will be given a dividend of $0.125 per share. This represents a $0.50 annualized dividend and a dividend yield of 1.75%. The ex-dividend date of this dividend is Wednesday, May 17th. Select Medical’s dividend payout ratio is presently 35.21%.
Insider Buying and Selling
In related news, VP Robert G. Breighner, Jr. sold 10,044 shares of Select Medical stock in a transaction dated Monday, May 8th. The stock was sold at an average price of $29.45, for a total value of $295,795.80. Following the completion of the sale, the vice president now owns 32,989 shares of the company’s stock, valued at approximately $971,526.05. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other Select Medical news, VP Robert G. Breighner, Jr. sold 10,044 shares of Select Medical stock in a transaction dated Monday, May 8th. The stock was sold at an average price of $29.45, for a total transaction of $295,795.80. Following the completion of the transaction, the vice president now owns 32,989 shares of the company’s stock, valued at approximately $971,526.05. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO David S. Chernow sold 139,550 shares of the business’s stock in a transaction that occurred on Monday, February 27th. The stock was sold at an average price of $27.30, for a total value of $3,809,715.00. Following the completion of the sale, the chief executive officer now owns 839,550 shares of the company’s stock, valued at approximately $22,919,715. The disclosure for this sale can be found here. In the last 90 days, insiders sold 199,594 shares of company stock valued at $5,589,511. 19.14% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
A number of research firms have recently commented on SEM. Deutsche Bank Aktiengesellschaft increased their target price on shares of Select Medical from $35.00 to $37.00 in a report on Monday, May 8th. TheStreet raised shares of Select Medical from a “c+” rating to a “b” rating in a report on Wednesday. Benchmark reissued a “buy” rating and issued a $39.00 target price on shares of Select Medical in a report on Monday, February 27th. Royal Bank of Canada upped their price objective on Select Medical from $32.00 to $38.00 in a research note on Monday, May 8th. Finally, StockNews.com assumed coverage on Select Medical in a research note on Thursday. They issued a “buy” rating for the company. One research analyst has rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, Select Medical has a consensus rating of “Moderate Buy” and a consensus price target of $35.75.
About Select Medical
Select Medical Holdings Corp. engages in the provision of medical rehabilitation services. It operates through the following business segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation and Concentra. The Critical Illness Recovery Hospital segment serves patients with debilitating injuries and rehabilitation needs that cannot be adequately cared in a medically intensive environment, such as a skilled nursing facility.
- Get a free copy of the StockNews.com research report on Select Medical (SEM)
- MarketBeat Week in Review – 5/15 – 5/19
- Applied Materials: Cracks In The Chip Recovery Or Time To Buy?
- Deere & Company Rallies On Farm Equipment Boom, Bullish Outlook
- How Many Roth IRAs Can You Have?
- Why You Should Consider Buying Nvidia Ahead Of Earnings
Want to see what other hedge funds are holding SEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Select Medical Holdings Co. (NYSE:SEM – Get Rating).
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.